Wednesday, May 31, 2023
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
    • Rewind
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
  • Rewind
Home | Business | Dr Reddys Prestige Biopharma Partner To Commercialise Trastuzumab Biosimilar For Cancer Treatment

Dr Reddy’s, Prestige BioPharma partner to commercialise Trastuzumab biosimilar for cancer treatment

Hyderabad: Hyderabad-based Dr Reddy’s Laboratories and Prestige BioPharma have entered into a binding agreement for an exclusive partnership for the supply and commercialisation of Prestige BioPharma’s proposed trastuzumab biosimilar in select countries in Latin America and Southeast Asia. Prestige BioPharma’s trastuzumab (HD201) is a proposed biosimilar to Roche’s Herceptin and can be prescribed for the […]

By Telangana Today
Updated On - 10:38 AM, Thu - 9 December 21
Dr Reddy’s, Prestige BioPharma partner to commercialise Trastuzumab biosimilar for cancer treatment
whatsapp facebook twitter telegram

Hyderabad: Hyderabad-based Dr Reddy’s Laboratories and Prestige BioPharma have entered into a binding agreement for an exclusive partnership for the supply and commercialisation of Prestige BioPharma’s proposed trastuzumab biosimilar in select countries in Latin America and Southeast Asia.

Prestige BioPharma’s trastuzumab (HD201) is a proposed biosimilar to Roche’s Herceptin and can be prescribed for the treatment of HER2 positive breast and metastatic gastric cancer.

Trastuzumab targets human epidermal growth factor 2 (HER2). In some types of cancer cells, HER2 is overexpressed and stimulates the growth of the cancer cells. Trastuzumab works by selectively binding to HER2, thereby stopping the growth of these cancer cells.

The license agreement grants Dr Reddy’s the exclusive rights to commercialise the proposed biosimilar in select countries in Latin America and Southeast Asia. 

Under this partnership, Prestige BioPharma will be responsible for sustainable commercial supply of HD201 from its manufacturing facilities in Osong, South Korea, while Dr Reddy’s will be responsible for local registrations, marketing and sales in the licensed territories.

Lisa S Park, CEO of Prestige BioPharma, said, “Dr Reddy’s is the ideal partner to commercialise our lead biosimilar in these territories. With this collaboration, we look forward to further strengthening the value of our biosimilar programs in global markets.”

MV Ramana, CEO, Branded Markets (India & Emerging Markets), Dr Reddy’s, added, the partnership with Prestige BioPharma will help both the companies combine established expertise in the biosimilars with the commercial strengths and growth ambition in these markets.

“This is in line with our stated intention to create a portfolio of oncology products and expand our biosimilar offerings in emerging markets,” Ramana added.


Now you can get handpicked stories from Telangana Today on Telegram everyday.

Click the link to subscribe. Click to follow Telangana Today Facebook page and Twitter .

  • Follow Us :
  • Tags
  • Dr Reddy’s Laboratories
  • Hyderabad
  • Prestige BioPharma

Related News

  • Telangana government constructed 14 public libraries in last 1 year in Hyderabad: Talasani

    Telangana government constructed 14 public libraries in last 1 year in Hyderabad: Talasani

  • Hyderabad team advances to semifinal of CM Cup Football Championship

    Hyderabad team advances to semifinal of CM Cup Football Championship

  • Hyderabad: Man electrocuted while cutting down tree in Falaknuma

    Hyderabad: Man electrocuted while cutting down tree in Falaknuma

  • Suyanshu Basa clinches two medals at CM Cup Swimming Championship

    Suyanshu Basa clinches two medals at CM Cup Swimming Championship

  • Telangana: Man sells four-year-old son for Rs 3 lakh, cops return child to his mother

    Telangana: Man sells four-year-old son for Rs 3 lakh, cops return child to his mother

  • Exotic animals displayed at pub: Forest dept officials detain seven persons in Hyderabad

    Exotic animals displayed at pub: Forest dept officials detain seven persons in Hyderabad

Latest News

  • About 40 medical colleges lose recognition for non-compliance with NMC standards

    5 hours ago
  • Number of Rs 500 fake currency notes rose by 14.6 per cent: RBI

    5 hours ago
  • Opinion: AI and ethical dilemmas

    5 hours ago
  • Editorial: Mammoth task in Manipur

    5 hours ago
  • French Open: Seyboth Wild stuns Medvedev in five-set thriller

    5 hours ago
  • Tech Tok: Neuralink gets approval for human study

    5 hours ago
  • Number of frauds rose in FY23, amount involved halved: RBI data

    6 hours ago
  • New blood test to predict if cognitively healthy person will develop Alzheimer’s

    6 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam